The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 5-Oil hits highest since March collapse on vaccine, Biden transition

Tue, 24th Nov 2020 03:52

* AstraZeneca says COVID-19 vaccine can be 90% effective

* Trump, officials give nod to formal Biden transition

* OPEC experts meet ahead of next week's crucial gathering

* Coming up: API inventory report, 2130 GMT
(Updates prices, adds quote)

By Alex Lawler

LONDON, Nov 24 (Reuters) - Oil hit its highest since in
March on Tuesday, rising towards $47 a barrel, as a third
promising coronavirus vaccine spurred demand recovery hopes and
U.S. President-elect Joe Biden received the go-ahead to begin
his transition.

AstraZeneca said on Monday its COVID-19 shot was 70%
effective in trials and could be up to 90% effective, giving the
fight against the pandemic a third vaccine. This follows
positive results from Pfizer/BioNTech and Moderna.

Brent crude rose 45 cents, or 1%, to $46.51 a barrel
by 1110 GMT and hit a session high of $46.72, its highest since
March 6. U.S. West Texas Intermediate crude gained 47
cents, or 1.1%, to $43.53.

"The fight against the coronavirus is intensifying and is
proving to be increasingly successful," said Tamas Varga of
broker PVM. "Next year's oil demand estimates are bound to be
amended upwards."

This is Brent's highest since the collapse of an earlier
OPEC-led output pact, just as demand was starting to crater in
March due to the developing pandemic, sent prices crashing.

Also supporting oil and wider financial markets, U.S.
President Donald Trump on Monday allowed officials to proceed
with a transition to Joe Biden's administration.

"In the short-term, this is good for markets in general as
well as for the oil market," said Bjarne Schieldrop of SEB.

Expectations that U.S. crude inventories edged lower last
week also added support. The first of this week's U.S. supply
reports is due at 2130 GMT from the American Petroleum
Institute.

After the previous output pact collapsed leading to a brief
Saudi Arabia-Russia price war, OPEC and allies agreed to record
high output cuts to support prices.

OPEC+, as the group is known, is expected to roll over
current cuts into 2021 at meetings on Nov. 30-Dec. 1, following
technical talks this week.

(Additional reporting by Jessica Jaganathan; editing by Jason
Neely and Louise Heavens)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.